Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Hurbanovo – page 5

340 clinical trials in Hurbanovo, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Hurbanovo at a glance
340
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

340 trials in Hurbanovo

Open in trial search

Gastric cancer+1

Recruiting

Study of AZD0901 (sonesitatug vedotin) with capecitabine ± rilvegostomig in adults with advanced stomach or esophageal cancer (Claudin‑18.2‑positive, HER2‑negative)

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:AZD0901
  • Sponsor:AstraZeneca AB

Colitis ulcerative+2

Recruiting

Study of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:LY4395089
  • Sponsor:Eli Lilly & Co.

Crohn's disease

Recruiting

A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Eli Lilly & Co.

Ovarian cancer

Recruiting

A study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Merck Sharp & Dohme LLC

Phase 2 Study of Rinatabart Sesutecan with Pegfilgrastim in Adults with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Glatiramer Acetate
  • Sponsor:Genmab A/S

Obesity+1

Recruiting

A study to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight and type 2 diabetes

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:LY3841136 sodium
  • Sponsor:Eli Lilly & Co.

Comparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Amgen Inc.

A study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Pfizer Inc.

A study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

Pain+3

Recruiting

A study to evaluate the safety and how the body processes the combination of ibuprofen and paracetamol in children and adolescents with acute pain

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ibuprofen
  • Sponsor:Aft Pharmaceuticals Limited

A study to evaluate the efficacy and safety of etrasimod arginine in children with moderately to severely active ulcerative colitis

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:0–17 years
  • Substances:Etrasimod Arginine
  • Sponsor:Pfizer Inc.

Other cities in Slovakia

The busiest research cities in the country

All 88 cities in Slovakia

Clinical research in Hurbanovo

What the registry says about research in the country

01 Women's Health Research

Clinical studies focusing on contraceptive medicine and reproductive health are evaluating innovative delivery systems for birth control methods. These trials aim to assess new approaches to pregnancy prevention, examining both effectiveness and patient comfort.

  • Contraceptive Efficacy Studies
  • Reproductive Health Innovation
  • Drug Delivery Systems

Research includes comparative analysis between different contraceptive methods, with particular attention to safety and tolerability profiles for long-term use.

02 Medical Device Innovation

Developments in vaginal delivery systems represent a significant focus in current clinical research. These studies are exploring alternative methods for medication administration to enhance patient compliance and treatment effectiveness.

  • Novel Drug Delivery Mechanisms
  • Long-term Effectiveness
  • Patient Tolerance Assessment

The research emphasizes multicentre collaboration to ensure comprehensive evaluation of new medical technologies.

03 Hormonal Research

Studies examining hormonal contraception methods are evaluating various administration routes and their impact on efficacy. The research encompasses both traditional and innovative approaches to hormone-based treatments.

  • Hormonal Therapy Development
  • Comparative Effectiveness
  • Safety Monitoring

These trials are designed to expand contraceptive options while maintaining high safety standards.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.